Sep 24, 2024 08:01AM
May 1, 2024 08:47AM
May 1, 2024 08:47AM
May 1, 2024 08:47AM
Apr 10, 2024 08:00AM
Feb 7, 2024 08:47AM
Jan 24, 2024 08:47AM Altamira Therapeutics (CYTO) Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
Jan 24, 2024 08:47AM
Jan 24, 2024 08:47AM
Nov 17, 2023 09:05AM
Nov 17, 2023 09:04AM
Sep 14, 2023 08:47AM
Sep 14, 2023 08:47AM
Sep 12, 2023 07:30AM Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
Jun 15, 2023 08:49AM
Jun 15, 2023 08:47AM
May 24, 2023 08:54AM
May 24, 2023 08:47AM
May 16, 2023 07:32AM
May 16, 2023 07:30AM
Apr 12, 2023 09:31AM Altamira Therapeutics (CYTO) Reports Publication of Positive Results from Phase 2 Trial with AM-125
Apr 12, 2023 09:30AM
Apr 10, 2023 08:48AM
Apr 10, 2023 08:47AM
Feb 27, 2023 08:47AM
Feb 27, 2023 08:47AM
Feb 27, 2023 08:47AM
Dec 19, 2022 08:47AM Altamira Therapeutics (CYTO) Issues Year-End 2022 Business Update
Dec 19, 2022 08:47AM
Dec 19, 2022 08:47AM
Nov 30, 2022 08:47AM
Nov 30, 2022 08:47AM
Nov 30, 2022 08:07AM
Nov 30, 2022 08:07AM
Nov 8, 2022 08:47AM Altamira Therapeutics (CYTO) Announces Data Published in Peer-Reviewed Journal Demonstrate Protective Effects of Bentrio under Controlled Grass Pollen Exposure
Nov 8, 2022 08:47AM
Nov 8, 2022 08:47AM
Oct 3, 2022 08:47AM
Oct 3, 2022 08:47AM
Oct 3, 2022 08:47AM
Sep 27, 2022 08:48AM
Sep 27, 2022 08:47AM Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis
Sep 27, 2022 08:47AM
Aug 30, 2022 09:26AM
Aug 30, 2022 09:24AM
Jul 25, 2022 08:49AM
Jul 25, 2022 08:47AM
Jul 25, 2022 08:47AM
Jun 29, 2022 07:34AM Altamira Therapeutics (CYTO) Secures Marketing & Distribution Agreements To Expand Sales Channels of Bentrio into Egypt and Pakistan
Jun 29, 2022 07:30AM

322,904 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All